Skip to content

SUSCEPTIBILITY AND EVOLUTION OF COVID-19 DISEASE STUDY

24 Apr 2020
SUSCEPTIBILITY AND EVOLUTION OF COVID-19 DISEASE STUDY

tellmeGen, in association with the Institute of Immunology, University Medicine in Rostock (Germany), led by Prof. Dr. med. habil. Hans-Juergen Thiesen, starts a pioneering genetic study related to the susceptibility to SARS-CoV2 infections and its subsequent COVID-19 disease.

Our goal is focused on identifying predictive epi-/genetic markers that identify people at risk of suffering from severe COVID-19 disease, regardless of age, sex, viral load and comorbidities.

Therefore, we are going to split patients with a positive diagnosis of COVID-19 into the following strata:

Group I: SARS-CoV2 positive without hospital admission (asymptomatic or mild symptoms).

Group II: SARS-CoV2 positive with hospital admission (supplemental oxygen measures).

Group III: SARS-CoV2 positive with admission to the Intensive Care Unit (ICU) (need for assisted breathing).

New In

Close
Login
Close
Edit Option
Close
Have Questions?
Close
Notify Me
Close
is added to your shopping cart.
Close
Close
Close

Before you leave...

Take 10% off your first order

10% off

Enter the code below at checkout to get 10% off your first order

SAVE10

Continue Shopping
Recommended 6